These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28682319)

  • 21. Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers.
    Mactier H; McLaughlin P; Gillis C; Osselton MD
    Am J Perinatol; 2017 Jul; 34(9):918-921. PubMed ID: 28320034
    [No Abstract]   [Full Text] [Related]  

  • 22. Elucidating the Relationship Between Maternal Diabetes and Neonatal Abstinence Syndrome: A 2017-2018 Project WATCH Study in Rural Appalachia.
    Jennings A; John C; Lilly C; Hamilton C; Umer A
    Adv Neonatal Care; 2022 Jun; 22(3):239-245. PubMed ID: 34138790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates.
    Leeman LM; Brown SA; Albright B; Skipper B; Hsi A; Rayburn WF
    J Matern Fetal Neonatal Med; 2011 Jul; 24(7):955-9. PubMed ID: 21142769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin conductance in neonates suffering from abstinence syndrome and unexposed newborns.
    Schubach NE; Mehler K; Roth B; Korsch E; Laux R; Singer D; von der Wense A; Treszl A; Hünseler C
    Eur J Pediatr; 2016 Jun; 175(6):859-68. PubMed ID: 27026377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buprenorphine: a new player in neonatal withdrawal syndrome.
    Nanda S; Brant R; Regier M; Yossuck P
    W V Med J; 2015; 111(1):16-21. PubMed ID: 25665273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
    Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E
    Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth during the first year in infants affected by neonatal abstinence syndrome.
    Corr TE; Schaefer EW; Paul IM
    BMC Pediatr; 2018 Nov; 18(1):343. PubMed ID: 30396334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
    Liu AJ; Jones MP; Murray H; Cook CM; Nanan R
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal Abstinence Syndrome among Infants Born to Mothers with Sickle Cell Hemoglobinopathies.
    Brown JA; Sinkey RG; Steffensen TS; Louis-Jacques AF; Louis JM
    Am J Perinatol; 2020 Feb; 37(3):326-332. PubMed ID: 31756755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.
    Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW
    Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal Abstinence Syndrome in East Tennessee: Characteristics and Risk Factors among Mothers and Infants in One Area of Appalachia.
    Erwin PC; Meschke LL; Ehrlich SF; Lindley LC
    J Health Care Poor Underserved; 2017; 28(4):1393-1408. PubMed ID: 29176103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal Abstinence Syndrome (NAS) in Southwestern Border States: Examining Trends, Population Correlates, and Implications for Policy.
    Hussaini KS; Garcia Saavedra LF
    Matern Child Health J; 2018 Sep; 22(9):1352-1359. PubMed ID: 29572587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of opiate-induced neonatal abstinence syndrome.
    Healy D; English F; Daniels A; Ryan CA
    Ir Med J; 2014 Feb; 107(2):46. PubMed ID: 24654482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription opioid epidemic and infant outcomes.
    Patrick SW; Dudley J; Martin PR; Harrell FE; Warren MD; Hartmann KE; Ely EW; Grijalva CG; Cooper WO
    Pediatrics; 2015 May; 135(5):842-50. PubMed ID: 25869370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a canadian multisite cohort study.
    Ordean A; Kahan M; Graves L; Abrahams R; Kim T
    J Obstet Gynaecol Can; 2015 Mar; 37(3):252-257. PubMed ID: 26001872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.
    McQueen KA; Murphy-Oikonen J; Desaulniers L
    Matern Child Health J; 2015 Aug; 19(8):1756-65. PubMed ID: 25656717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Universal maternal drug testing in a high-prevalence region of prescription opiate abuse.
    Wexelblatt SL; Ward LP; Torok K; Tisdale E; Meinzen-Derr JK; Greenberg JM
    J Pediatr; 2015 Mar; 166(3):582-6. PubMed ID: 25454935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome.
    Burns L; Mattick RP
    Drug Alcohol Rev; 2007 Sep; 26(5):487-92. PubMed ID: 17701511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.
    Brogly SB; Saia KA; Walley AY; Du HM; Sebastiani P
    Am J Epidemiol; 2014 Oct; 180(7):673-86. PubMed ID: 25150272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.